Auro Laboratories Ltd.
BSE: 530233 | Sector: Health care |
NSE: N.A. | ISIN Code: INE292C01011 |
BSE 12:28 | 16 May | 92.85 |
-3.50 (-3.63%) |
OPEN
96.75 |
HIGH
96.75 |
LOW
92.85 |
NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
OPEN | 96.75 |
PREVIOUS CLOSE | 96.35 |
VOLUME | 1295 |
52-Week high | 195.00 |
52-Week low | 87.00 |
P/E | 14.81 |
Mkt Cap.(Rs cr) | 58 |
Buy Price | 92.60 |
Buy Qty | 5.00 |
Sell Price | 92.85 |
Sell Qty | 89.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Auro Laboratories Ltd. (AUROLABS) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 32.98 | 40.69 | 34.36 | 35.29 | 29.52 |
Other Income | 0.81 | 0.59 | 0.59 | 0.36 | 0.29 |
Total Income | 33.79 | 41.27 | 34.95 | 35.66 | 29.80 |
Total Expenditure | 29.26 | 32.48 | 28.92 | 30.52 | 25.36 |
Operating Profit | 4.53 | 8.79 | 6.03 | 5.14 | 4.44 |
Interest | 0.43 | 0.21 | 0.37 | 0.60 | 1.04 |
Gross Profit | 4.10 | 8.58 | 5.66 | 4.54 | 3.40 |
Depreciation | 0.78 | 0.76 | 0.79 | 0.79 | 0.73 |
PBT | 3.32 | 7.82 | 4.87 | 3.76 | 2.67 |
Tax | 0.93 | 2.15 | 1.28 | 0.94 | 0.00 |
Net Profit/(Loss) | 2.39 | 5.67 | 3.59 | 2.82 | 2.67 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 2.39 | 5.67 | 3.59 | 2.82 | 2.67 |
Equity Share Capital | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 3.83 | 9.10 | 5.76 | 4.52 | 4.28 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices